Home >
Medicine Info >
Glaritus 100 IU Injection
Loading interface...

Glaritus 100 IU Injection

Manufactured byWOCKHARDT LTD
ContainsInsulin Glargine
Description
Glaritus 100 IU Injection is used for the treatment of diabetes in children and adults. It is a long-acting insulin that consistently works for several hours after injection and provides effective blood sugar control throughout the day. Glaritus 100 IU Injection may result in low blood sugar levels and you may feel hungry, irritable, dizzy, anxious, or shaky. It is always recommended to eat or drink a fast-acting source of sugar (fruit juice, candy, raisins, etc.) to quickly treat these symptoms. Consult your doctor if these symptoms stay for a long time or if they become severe. Other side effects include weight gain and reaction at the injection side such as redness, itchiness and swelling in the skin, thickening of the skin, etc. Avoid consumption of alcohol as it may also lower your blood sugar levels. Glaritus 100 IU Injection should be administered exactly as advised by your doctor. This medicine is injected under your skin. Take it at the same time every day to maintain a constant level of this medicine in your body. Do not skip doses or discontinue the treatment without consulting your doctor as it may cause an increase in your blood sugar levels. Follow a proper diet routine and do regular exercise along with this medicine to get the best results. Glaritus 100 IU Injection is not recommended if you are allergic to it. Inform your doctor if you have liver or kidney problems. Do not use this medicine in children below 6 years of age. If you are pregnant or are planning a pregnancy or breastfeeding, take this medication only if prescribed by your doctor.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Glaritus 100 IU Injection

  • Decreased blood glucose levels
  • Reaction at the injection site
  • Skin Rash
  • Thickening or hollowing of the skin at the injection site
  • Weight gain

Uses of Glaritus 100 IU Injection

What is it prescribed for?

  • Type 1 Diabetes mellitus
  • Type II Diabetes Mellitus
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    Glaritus 100 IU Injection begins to show its effect within 1.5 to 2 hours after administration.
  • How long do the effects of this medicine last?
    The effect of Glaritus 100 IU Injection lasts for an average duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with Glaritus 100 IU Injection as it may alter your blood sugar levels. This may cause side effects such as dizziness, drowsiness, increased thirst, increased hunger, mood changes, extreme fatigue, etc.
  • Is this a habit forming medicine?
    No habit-forming tendency was reported with Glaritus 100 IU Injection.
  • Can this medicine be taken during pregnancy?
    Glaritus 100 IU Injection is not recommended for use in pregnant as animal studies indicate that it may harm your foetus. Consult your doctor if you are pregnant.
  • Can this medicine be taken while breast-feeding?
    It is not known whether Glaritus 100 IU Injection passes into the breastmilk in significant amounts. Hence, take this medicine only if prescribed by your doctor.

Allergy

Avoid taking Glaritus 100 IU Injection if you are allergic to it. However, seek immediate medical attention if you notice any symptoms of allergic reactions such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Glaritus 100 IU Injection is not recommended for use in pregnant as animal studies indicate that it may harm your foetus. Consult your doctor if you are pregnant.

Breast-feeding

It is not known whether Glaritus 100 IU Injection passes into the breastmilk in significant amounts. Hence, take this medicine only if prescribed by your doctor.
General warnings

Diabetic Ketoacidosis

Diabetic ketoacidosis is a condition of increased blood acids (ketones). Glaritus 100 IU Injection is not recommended for the treatment of diabetic ketoacidosis due to the delayed onset of action. Your doctor will determine the suitable treatment options based on your clinical condition.

Subcutaneous use only

Glaritus 100 IU Injection is meant for subcutaneous administration (under the skin) only. The long duration of action of this medicine is dependent on a subcutaneous administration. It should not be administered intravenously (into the veins) or intramuscularly (into the muscles).

Hypoglycemia (Low blood sugar levels)

Glaritus 100 IU Injection may cause low blood sugar levels. Hence, regular monitoring of your blood sugar levels is recommended. Your doctor may advise you to carry a sugar candy to counteract the effects of low blood sugar levels.

Use with other insulins

Glaritus 100 IU Injection should not be diluted or mixed with any other insulin or solution as it may alter the effects of other insulins when administered together and/or increase the risk of side effects.

Use in children

Glaritus 100 IU Injection is not recommended for use in children less than 6 years of age due to lack of safety and efficacy data.

Allergic Reactions at the injection Site

Injection site reactions that may occur with Glaritus 100 IU Injection include redness, pain, itching, swelling or hives (itchy, painful eruptions that sting). Continuous rotation of the injection site within a given area is recommended to help reduce or prevent these reactions. These reactions usually resolve in a few days to a few weeks.

Driving or operating machines

Your ability to drive or operate machines may be negatively affected due to low or high blood glucose levels. Hence, avoid driving or operating machines if you experience any symptoms like dizziness, blurred vision, etc. while taking this medicine.

Missed Dose

If you miss a dose of Glaritus 100 IU Injection, contact your doctor for further instructions. You should not use more than one dose in a 24-hour period unless specifically instructed by your doctor.

Overdose

Seek immediate medical attention or contact your doctor if an overdose of Glaritus 100 IU Injection is suspected. Hypoglycaemia (low blood glucose levels) may occur in case of an overdose with symptoms such as extreme weakness, blurred vision, sweating, trouble speaking, tremors, dizziness, confusion, etc. In cases of mild hypoglycemic episodes, oral glucose or sugary products can be used to avoid severe hypoglycaemia.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with Glaritus 100 IU Injection as it may alter your blood sugar levels. This may cause side effects such as dizziness, drowsiness, increased thirst, increased hunger, mood changes, extreme fatigue, etc.
Interaction with Medicine

Corticosteroids

ACE inhibitors

Aspirin

Ciprofloxacin

Disease interactions

Kidney Disease

Glaritus 100 IU Injection should be used with caution if you have kidney problems as it may increase the risk of side effects. Your doctor may suggest tests to closely monitor your kidney functions. Regular monitoring of blood sugar levels is also recommended.

Hypokalaemia

Glaritus 100 IU Injection may increase the risk of hypokalaemia (low potassium levels in your blood). Hence, close monitoring of blood potassium levels is recommended if you are taking this medicine.

Liver Disease

Glaritus 100 IU Injection should be used with caution if you have liver problems as it may increase the risk of side effects. Your doctor may suggest tests to closely monitor your kidney functions. Regular monitoring of blood sugar levels is also recommended.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Carefully follow all the instructions given by your doctor. Do not administer Glaritus 100 IU Injection in larger or smaller amounts than prescribed. Never share an injection pen, cartridge, or syringe with another person, even if the needle has been changed. Avoid the use of this medicine if the solution is cloudy, coloured or contains solid particles. Avoid the discontinuation of this medicine without consulting your doctor as it may increase your blood sugar levels. Consult your doctor if you experience any side effects that persist or worsens. Regular monitoring of blood sugar levels and frequent follow-up visits with your doctor is recommended so that your doctor can evaluate your condition.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
Glaritus 100 IU Injection is a long-acting modified form of insulin that works similarly to human insulin. It improves blood sugar control by enhancing glucose uptake from the blood into body tissues and also by preventing the production of glucose in the liver.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Insulin, Antidiabetic agents

Schedule

Schedule G

Medicines.org.uk. 2021. ABASAGLAR 100 units/mL KwikPen solution for injection in a pre-filled pen - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 20 August 2021].

https://www.medicines.org.uk/emc/product/6901/smpc>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 20 August 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021081s024lbl.pdf>

Cunningham, A. and Freeman, A., 2021. Glargine Insulin. [online] Ncbi.nlm.nih.gov. Available at: < [Accessed 20 August 2021].

https://www.ncbi.nlm.nih.gov/books/NBK557756/>

Medicines.org.uk. 2021. [online] Available at: < [Accessed 20 August 2021].

https://www.medicines.org.uk/emc/files/pil.6901.pdf>

Drugs, H., 2021. Insulin Glargine (rDNA origin) Injection: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 20 August 2021].

https://medlineplus.gov/druginfo/meds/a600027.html>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 7 Sep 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.